Global Prostacyclin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Prostacyclin Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Epoprostenol Sodium
- 1.3.3 Treprostinil
- 1.3.4 Iloprost
- 1.3.5 Beraprost Sodium
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Prostacyclin Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 For Injection
- 1.4.3 For Oral
- 1.4.4 For Inhalation
- 1.5 Global Prostacyclin Market Size & Forecast
- 1.5.1 Global Prostacyclin Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Prostacyclin Sales Quantity (2020-2031)
- 1.5.3 Global Prostacyclin Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 United Therapeutics
- 2.1.1 United Therapeutics Details
- 2.1.2 United Therapeutics Major Business
- 2.1.3 United Therapeutics Prostacyclin Product and Services
- 2.1.4 United Therapeutics Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 United Therapeutics Recent Developments/Updates
- 2.2 Actelion (J & J)
- 2.2.1 Actelion (J & J) Details
- 2.2.2 Actelion (J & J) Major Business
- 2.2.3 Actelion (J & J) Prostacyclin Product and Services
- 2.2.4 Actelion (J & J) Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Actelion (J & J) Recent Developments/Updates
- 2.3 GSK
- 2.3.1 GSK Details
- 2.3.2 GSK Major Business
- 2.3.3 GSK Prostacyclin Product and Services
- 2.3.4 GSK Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 GSK Recent Developments/Updates
- 2.4 Teva
- 2.4.1 Teva Details
- 2.4.2 Teva Major Business
- 2.4.3 Teva Prostacyclin Product and Services
- 2.4.4 Teva Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Teva Recent Developments/Updates
- 2.5 Toray
- 2.5.1 Toray Details
- 2.5.2 Toray Major Business
- 2.5.3 Toray Prostacyclin Product and Services
- 2.5.4 Toray Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Toray Recent Developments/Updates
- 2.6 Tide Pharma
- 2.6.1 Tide Pharma Details
- 2.6.2 Tide Pharma Major Business
- 2.6.3 Tide Pharma Prostacyclin Product and Services
- 2.6.4 Tide Pharma Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Tide Pharma Recent Developments/Updates
- 2.7 Bayer AG
- 2.7.1 Bayer AG Details
- 2.7.2 Bayer AG Major Business
- 2.7.3 Bayer AG Prostacyclin Product and Services
- 2.7.4 Bayer AG Prostacyclin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Bayer AG Recent Developments/Updates
3 Competitive Environment: Prostacyclin by Manufacturer
- 3.1 Global Prostacyclin Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Prostacyclin Revenue by Manufacturer (2020-2025)
- 3.3 Global Prostacyclin Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Prostacyclin by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Prostacyclin Manufacturer Market Share in 2024
- 3.4.3 Top 6 Prostacyclin Manufacturer Market Share in 2024
- 3.5 Prostacyclin Market: Overall Company Footprint Analysis
- 3.5.1 Prostacyclin Market: Region Footprint
- 3.5.2 Prostacyclin Market: Company Product Type Footprint
- 3.5.3 Prostacyclin Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Prostacyclin Market Size by Region
- 4.1.1 Global Prostacyclin Sales Quantity by Region (2020-2031)
- 4.1.2 Global Prostacyclin Consumption Value by Region (2020-2031)
- 4.1.3 Global Prostacyclin Average Price by Region (2020-2031)
- 4.2 North America Prostacyclin Consumption Value (2020-2031)
- 4.3 Europe Prostacyclin Consumption Value (2020-2031)
- 4.4 Asia-Pacific Prostacyclin Consumption Value (2020-2031)
- 4.5 South America Prostacyclin Consumption Value (2020-2031)
- 4.6 Middle East & Africa Prostacyclin Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Prostacyclin Sales Quantity by Type (2020-2031)
- 5.2 Global Prostacyclin Consumption Value by Type (2020-2031)
- 5.3 Global Prostacyclin Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Prostacyclin Sales Quantity by Application (2020-2031)
- 6.2 Global Prostacyclin Consumption Value by Application (2020-2031)
- 6.3 Global Prostacyclin Average Price by Application (2020-2031)
7 North America
- 7.1 North America Prostacyclin Sales Quantity by Type (2020-2031)
- 7.2 North America Prostacyclin Sales Quantity by Application (2020-2031)
- 7.3 North America Prostacyclin Market Size by Country
- 7.3.1 North America Prostacyclin Sales Quantity by Country (2020-2031)
- 7.3.2 North America Prostacyclin Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Prostacyclin Sales Quantity by Type (2020-2031)
- 8.2 Europe Prostacyclin Sales Quantity by Application (2020-2031)
- 8.3 Europe Prostacyclin Market Size by Country
- 8.3.1 Europe Prostacyclin Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Prostacyclin Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Prostacyclin Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Prostacyclin Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Prostacyclin Market Size by Region
- 9.3.1 Asia-Pacific Prostacyclin Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Prostacyclin Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Prostacyclin Sales Quantity by Type (2020-2031)
- 10.2 South America Prostacyclin Sales Quantity by Application (2020-2031)
- 10.3 South America Prostacyclin Market Size by Country
- 10.3.1 South America Prostacyclin Sales Quantity by Country (2020-2031)
- 10.3.2 South America Prostacyclin Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Prostacyclin Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Prostacyclin Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Prostacyclin Market Size by Country
- 11.3.1 Middle East & Africa Prostacyclin Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Prostacyclin Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Prostacyclin Market Drivers
- 12.2 Prostacyclin Market Restraints
- 12.3 Prostacyclin Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Prostacyclin and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Prostacyclin
- 13.3 Prostacyclin Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Prostacyclin Typical Distributors
- 14.3 Prostacyclin Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Prostacyclin market size was valued at US$ 2791 million in 2024 and is forecast to a readjusted size of USD 4439 million by 2031 with a CAGR of 6.9% during review period.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.
North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.
In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.
This report is a detailed and comprehensive analysis for global Prostacyclin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prostacyclin market size and forecasts, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2020-2031
Global Prostacyclin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2020-2031
Global Prostacyclin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2020-2031
Global Prostacyclin market shares of main players, shipments in revenue ($ Million), sales quantity (K Unit), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prostacyclin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prostacyclin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma, Bayer AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Prostacyclin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Market segment by Application
For Injection
For Oral
For Inhalation
Major players covered
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostacyclin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prostacyclin, with price, sales quantity, revenue, and global market share of Prostacyclin from 2020 to 2025.
Chapter 3, the Prostacyclin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostacyclin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Prostacyclin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prostacyclin.
Chapter 14 and 15, to describe Prostacyclin sales channel, distributors, customers, research findings and conclusion.